Contrast-induced nephropathy in patients at risk of renal failure undergoing computed tomography: Systematic review and meta-analysis of randomized controlled trials;Nefropatía inducida por contraste en pacientes de riesgo con insuficiencia renal explorados con tomografía computarizada: Revisión sistemática y metaanálisis de ensayos clínicos aleatorizados

Medicina Clinica

Volumn 135, Issue 8, 2010, Pages 343-350

  Arana, Estanislao ^a   Catalá López, Ferrán ^b  

^a Fundacion Instituto de Investigacion en Servicios de Salud   (Spain)

^b Division de Farmacoepidemiologia y Farmacovigilancia   (Spain)

Author keywords

Computed tomography; Contrast induced nephropathy; Iodinated contrast; Kidney disease; Meta analysis; Renal insufficiency

Indexed keywords

CONTRAST MEDIUM; CREATININE; DIATRIZOATE; IOBITRIDOL; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOVERSOL; IOXAGLIC ACID; IOXILAN;

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DATA EXTRACTION; EMBASE; HUMAN; KIDNEY FAILURE; MANTEL HAENSZEL TEST; MEDLINE; META ANALYSIS; MORBIDITY; NEPHROTOXICITY; OSMOLARITY; RISK; SOCIETY; SYSTEMATIC REVIEW;

CONTRAST MEDIA; HUMANS; KIDNEY DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956172499     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.01.035     Document Type: Article

References (30)

1. J.H. Ellis, and R.H. Cohan Reducing the risk of contrast-induced nephropathy: A perspective on the controversies AJR Am J Roentgenol 192 2009 1544 1549
2. R.W. Katzberg, and C. Haller Contrast-induced nephrotoxicity: Clinical landscape Kidney Int Suppl 100 2006 S3 S7
3. S.K. Morcos Contrast-induced nephropathy: Are there differences between low osmolar and iso-osmolar iodinated contrast media? Clin Radiol 64 2009 468 472
4. E.C. Lasser, S.G. Lyon, and C.C. Berry Reports on contrast media reactions: Analysis of data from reports to the US Food and Drug Administration Radiology 203 1997 605 610
5. P.A. McCullough, R. Wolyn, L.L. Rocher, R.N. Levin, and W.W. O'Neill Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
6. D. Reddan, M. Laville, and V.D. Garovic Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol 22 2009 333 351
7. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
8. M. Rudnick, and H. Feldman Contrast-induced nephropathy: What are the true clinical consequences? Clin J Am Soc Nephrol 3 2008 263 272
9. M. Tepel, P. Aspelin, and N. Lameire Contrast-induced nephropathy: A clinical and evidence-based approach Circulation 113 2006 1799 1806
10. Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. En: Higgins JPT, Green S, editores. Cochrane handbook for systematic reviews of interventions 5.0.1. Actualizado septiembre 2008 [consultado 16/10/2009]. Disponible en: http://www.cochrane-handbook.org/
11. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17 1996 1 12
12. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
13. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analysses BMJ 327 2003 557 560
14. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. En: Higgins JPT, Green S, editores. Cochrane handbook for systematic reviews of interventions 5.0.1. Actualizado septiembre 2008 [consultado 16/10/2009]. Disponible en: http://www.cochrane-handbook.org/
15. M.C. Heinrich, L. Hberle, V. Mller, W. Bautz, and M. Uder Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: Meta-analysis of randomized controlled trials Radiology 250 2009 68 86
16. H. Kolehmainen, and M. Soiva Comparison of Xenetix 300 and Visipaque 320 in patients with renal failure [abstr] Eur Radiol 13 2003 B32 B33
17. B.J. Barrett, R.W. Katzberg, H.S. Thomsen, N. Chen, D. Sahani, and G. Soulez Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: A double-blind comparison of iodixanol and iopamidol Invest Radiol 41 2006 815 821
18. H.S. Thomsen, S.K. Morcos, C.M. Erley, L. Grazioli, L. Bonomo, and Z. Ni The ACTIVE Trial: Comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography Invest Radiol 43 2008 170 178
19. S.A. Nguyen, P. Suranyi, J.G. Ravenel, P.K. Randall, P.B. Romano, and K.A. Strom Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: Effect on kidney function Radiology 248 2008 97 105
20. M.J. Kuhn, N. Chen, DV Sahani, D Reimer, EJ van Beek, and JP Heiken The PREDICT study: A randomized, double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 2008 151 157
21. R. Jabara, R.R. Gadesam, L.K. Pendyala, W.D. Knopf, N. Chronos, and J.P. Chen Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention Am J Cardiol 103 2009 1657 1662
22. N. Fontser, J. Bonal, and R. Romero Mtodos para la estimacin de la funcin renal Med Clin (Barc) 129 2007 513 518
23. R. Solomon, and B. Barrett Follow-up of patients with contrast-induced nephropathy Kidney Int Suppl 100 2006 S46 S50
24. S.D. Weisbord, M.K. Mor, A.L. Resnick, K.C. Hartwig, P.M. Palevsky, and M.J. Fine Incidence and outcomes of contrast-induced AKI following computed tomography Clin J Am Soc Nephrol 3 2008 1274 1281
25. P. Capasso, and S.D. Weisbord Comment on meta-analyses of trials comparing contrast media Radiology 252 2009 316
26. B.A. Molitoris Contrast nephropathy: Are short-term outcome measures adequate for quantification of long-term renal risk? Nat Clin Pract Nephrol 4 2008 594 595
27. M. Reed, P. Meier, U.U. Tamhane, K.B. Welch, M. Moscucci, and H.S. Gurm The relative renal safety of iodixanol compared with low-osmolar contrast media: A meta-analysis of randomized controlled trials JACC Cardiovasc Interv 2 2009 645 654
28. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, and M. Fahy A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation J Am Coll Cardiol 44 2004 1393 1399
29. F. Buitrago, J.I. Calvo, C. Gmez-Jimnez, L. Can, N.R. Robles, and E. Angulo Comparacin y concordancia de las ecuaciones de estimacin de filtrado glomerular de Cockcroft-Gault y MDRD en el diagnstico de enfermedad renal crnica oculta Nefrologa 28 2008 301 310
30. J. Almirall, M. Vaqueiro, E. Antn, M.L. Bar, V. Gonzlez, and E. Jaimez Prevalencia de la insuficiencia renal en la poblacin general mayor de 64 aos y episodios cardio-vasculares asociados Nefrologa 25 2005 655 662